Vicore Pharma Holding AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was SEK 111.89 million compared to SEK 60.7 million a year ago. Basic loss per share from continuing operations was SEK 1 compared to SEK 0.83 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.3 SEK | +3.72% | +6.00% | +22.00% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.00% | 176M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VICO Stock
- News Vicore Pharma Holding AB
- Vicore Pharma Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023